Infertility is deeply personal and affects 15% of the population. Many who struggle to conceive may never access care because of cost, inertia, or embarrassment associated with having difficulty conceiving. Those with infertility endure many anxieties, uncertainties, feelings of helplessness, and fears about the future -- and now, there's theCOVID-19 pandemicon top of it all.
Amid rapidly evolving public health guidelines, COVID-19 places healthcare providers in a similar climate of anxiety, uncertainty, feelings of helplessness, and fears about the future. Some of us physicians are developing a finer appreciation of the fear of the unknown that regularly complicates decision-making for our fertility patients. For those of us who see things as "black-and-white," and who may be overly dependent on guidelines and algorithms, it is likely a particularly difficult time. We all need to start appreciating nuances and gray areas in medicine. In learning to live with uncertainty, we should learn that with every plan, we must be flexible, ready to absorb new information, and ready to change direction with very little notice.
Over the past month, we have had many questions from our patients about COVID-19, pregnancy, and fertility. Here is a summary of common questions, current data, and recommendations from our national societies:
What are the risks of birth defects with COVID-19?
There are inadequate data to suggest any increased risk of birth defects with COVID-19 infection in the mother. This is reassuring, especially compared to the clearly increased risk of birth defects with varicella, rubella, and Zika virus infections in the mother. Further studies are needed.
Is there evidence of vertical transmission (mother-to-fetus transmission) of COVID-19?
There are inadequate data to suggest that COVID-19 can be passed from mother to fetus. Further studies are needed.
What do we know about the impact of COVID-19 virus infection in utero?
There are few reports of COVID-19-positive women who have given birth. One report from China suggests a possible increased risk of preterm delivery or intrauterine growth restriction; however, these limited data only address COVID-19 infection in late pregnancy. More data will emerge as women who were infected during the early stages of pregnancy progress to delivery over the coming months.
It is unclear whether the reported implications and outcomes associated with COVID-19 are the same as those with other types of coronavirus infections (such as SARS-CoV and MERS-CoV) during pregnancy. Further studies are urgently needed.
What are the national recommendations?
On March 17, the American Society of Reproductive Medicine (ASRM)published guidance for fertility specialists, which included five key recommendations: (1) suspend initiation of new treatment cycles; (2) strongly consider cancellation of all embryo transfers; (3) continue to care for patients who require urgent stimulation and cryopreservation (such as in cases of fertility preservation prior to impending cancer treatment); (4) suspend elective surgeries and non-urgent diagnostic procedures; and (5) minimize in-person interactions and increase utilization of telehealth.
In a March 31 update, ASRM reaffirmed this guidance and noted that they plan to reassess and issue updated recommendations every 2 weeks.
ASRM further noted that infertility should *not* be considered elective. Indeed, the World Health Organization and the American Medical Association have recognized infertility as a disease and a global public health issue.
What services are available and considered "urgent" during this pandemic?
This is a loaded question that likely needs to be individualized in different geographic regions. Regarding "urgent" surgeries, the American College of Surgeons states, "The medical need for a given procedure should be established by a surgeon with direct expertise in the relevant surgical specialty to determine what medical risks will be incurred by case delay."
Can patients begin treatment cycles right now?
For those couples desiring to start fertility treatments, unfortunately, there is currently a national stoppage in America (and also in Europe). While infertility is not elective, fertility treatments (except for very specific indications) are considered non-urgent treatment. While this will be re-evaluated every 2 weeks, we are currently in a "wait and see" situation. While everyone wants to reinstate care as soon as possible, we also need to be conscious of the rapidly evolving nature of COVID-19, and the need for our healthcare system to preserve, conserve, and even hopefully build up some reserves of valuable personal protective equipment during this worldwide COVID-19 public health emergency.
Can COVID-19 be transmitted with fertility treatments?
Specifically, can a woman without COVID-19 acquire it using sperm from a man with COVID-19? There are no data on this question, and further studies are needed.
Regarding fertility treatments, do we need to "quarantine" frozen sperm, oocytes, or embryos from COVID-19 patients?
Most fertility laboratories keep cryopreserved sperm, oocytes, or embryos from HIV-positive individuals in separate freezing tanks to "quarantine" them from frozen genetic material from the general population. Should these labs similarly "quarantine" frozen genetic material from COVID-19 patients separately? Further studies are needed.
Are there any risks of complications for fertility treatments in COVID-19 patients?
One potential risk with in vitro fertilization (IVF) is a phenomenon called "severe ovarian hyperstimulation syndrome," which may result in respiratory and cardiovascular difficulties. Given that COVID-19 infection can similarly result in respiratory and cardiovascular difficulties, it is unknown how women with COVID-19 will handle severe ovarian hyperstimulation syndrome. There are currently no reports of such complications.
Is it safe to try to conceive naturally?
For those couples who wish to try to conceive on their own, we individualize counseling based on patient health status. According to the CDC: diabetes, cardiovascular disease, morbid obesity, and immunocompromise are risk factors for critical illness from COVID-19 infection.
Similar to the 1918 flu pandemic, there are also some concerns that there may be a second wave of COVID-19 cases this fall or winter. Furthermore, we know that a small percentage of pregnant women may have a pregnancy complication (such as preterm labor, premature rupture of membranes, or eclamptic seizures) that may require a hospital stay; however, hospitalization during the COVID-19 pandemic may confer an increased risk of COVID-19 infection. Labor and delivery during this time of COVID-19 may be complicated by recommendations for early epidural placement, a higher chance of cesarean section, and emerging policies to separate mom and baby to minimize the risk of transmission of COVID-19 to the newborn.
For healthy patients who are willing to accept these risks if they conceive now and deliver during a possible resurgence of COVID-19 cases this fall or winter, it would be reasonable to try to conceive naturally.
Should the non-COVID-19 patient delay pregnancy during the current pandemic?
For those debating whether to continue contraception (versus whether to immediately start trying for a natural cycle pregnancy) during these uncertain times, it would be reasonable for certain patients to continue contraception.
While there are no recommendations about contraception for the American public, the European Society of Human Reproduction and Embryology advises that "all fertility patients considering or planning treatment, even if they do not meet the diagnostic criteria of COVID-19 infection, should avoid becoming pregnant at this time." This difference may be due to healthcare systems in certain European countries becoming overwhelmed by COVID-19 cases, leaving those healthcare workers with a lack of resources, personal protective equipment, and availability to treat routine patients outside of their pandemic response.
Finally, there remains much uncertainty about COVID-19, in general.
Infection rates: we will not have reliable data on true infection rates until widespread and accurate testing is more readily available.
Prevalence rates: we will not have reliable data on the number of patients who have recovered from COVID-19 until we have an accurate and reliable test for COVID-19 antibodies.
Fatality rates: without knowing how many cases we truly have, any estimate of true case fatality rates is doomed, except for closed systems like theDiamond Princesscruise ship.
We also have important unknowns, regarding the course of the pandemic, local hospital resources, and the effects on small businesses and the economy.
We empathize with our fertility patients who want to be pregnant already; unfortunately, so much remains unknown about COVID-19. The decision to try for conception, or to continue with contraception, is highly personal and needs to be individualized based on personal health, local conditions, and the current state of the pandemic in your local area.
Here are three questions that fertility patients should consider asking themselves:
Is my personal health and lifestyle in a place where I believe I can have a safe pregnancy?
Am I comfortable becoming pregnant and seeking care (including emergency care if complications arise) in an environment that may be wholly focused on combating COVID-19?
Am I confident that I will have the support I need during and after the pregnancy in a society that may still be practicing high levels of social distancing?
Our state and national leaders are right: this is a war, and we need to band together, so that we don't get overwhelmed. Our hope is that our collective global response to this pandemic will increase our sense of community and togetherness. We need to fight fear, panic, social isolation, and coronavirus cabin fever, while also remembering to take care of ourselves and each other. This too shall pass.
Nikki Kagan is a medical student, and Albert Hsu, MD, is a reproductive endocrinologist at the University of Missouri. All opinions expressed here are their own.
Read the rest here:
Fertility treatments in the age of COVID-19 - The Miami Times
- World Health Organization reference values for human semen characteristics [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Maternal metabolism and obesity: modifiable determinants of pregnancy outcome [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Brain imaging studies of appetite in the context of obesity and the menstrual cycle [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Options for fertility preservation in prepubertal boys [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Xenografting of testicular tissue from an infant human donor results in accelerated testicular maturation [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Karyotype of miscarriages in relation to maternal weight [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional regulation of thymic stromal lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional attenuation of human sperm by novel, non-surfactant spermicides: precise targeting of membrane physiology without affecting structure [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Pregnancy outcome in female childhood cancer survivors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Sperm donor limits that control for the 'relative' risk associated with the use of open-identity donors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Long-term cryostorage of sperm in a human sperm bank does not damage progressive motility concentration [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Screening for biomarkers of spermatogonia within the human testis: a whole genome approach [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Cross border reproductive care in six European countries [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Morphometric dimensions of the human sperm head depend on the staining method used [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- ESX1 gene expression as a robust marker of residual spermatogenesis in azoospermic men [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Innovative virtual reality measurements for embryonic growth and development [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Xenotransplantation of cryopreserved human ovarian tissue into murine back muscle [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of psychological distress in patients starting IVF treatment: infertility-specific versus general psychological characteristics [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological adjustment, knowledge and unmet information needs in women undergoing PGD [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Mothers of IVF and spontaneously conceived twins: a comparison of prenatal maternal expectations, coping resources and maternal stress [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological well-being and sexarche in women with polycystic ovary syndrome [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Is human fecundity declining in Western countries? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Human studies on genetics of the age at natural menopause: a systematic review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current knowledge of the aetiology of human tubal ectopic pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Economic contraction and birth outcomes: an integrative review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Teratogenic mechanisms of medical drugs [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Levels of semenogelin in human spermatozoa decrease during capacitation: involvement of reactive oxygen species and zinc [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Apoptosis and meiotic segregation in ejaculated sperm from Robertsonian translocation carrier patients [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- In humans, zona pellucida glycoprotein-1 binds to spermatozoa and induces acrosomal exocytosis [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Variants of the EPPIN gene affect the risk of idiopathic male infertility in the Han-Chinese population [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Epidermal clitoral inclusion cysts: not a rare complication of female genital mutilation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Obstetric outcomes after transfer of vitrified blastocysts [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Occasional involvement of the ovary in Ewing sarcoma [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Development and preliminary validation of the fertility status awareness tool: FertiSTAT [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Xenotransplantation of human ovarian tissue to nude mice: comparison between four grafting sites [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Involvement of CFTR in oviductal HCO3- secretion and its effect on soluble adenylate cyclase-dependent early embryo development [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Effect of endometriosis on the protein expression pattern of follicular fluid from patients submitted to controlled ovarian hyperstimulation for in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Clinical significance of sperm DNA damage in assisted reproduction outcome [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Fall in implantation rates following ICSI with sperm with high DNA fragmentation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Fertility after autologous ovine uterine-tubal-ovarian transplantation by vascular anastomosis to the external iliac vessels [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Uterus transplantation in the baboon: methodology and long-term function after auto-transplantation [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Transfer of a selected single blastocyst optimizes the chance of a healthy term baby: a retrospective population based study in Australia 2004-2007 [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Disclosure patterns of mode of conception among mothers and fathers-5-year follow-up of the Copenhagen Multi-centre Psychosocial Infertility (COMPI) cohort [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- A decade of sperm washing: clinical correlates of successful insemination outcome [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Sperm DNA integrity in cancer patients before and after cytotoxic treatment [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Speriolin is a novel human and mouse sperm centrosome protein [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- No influence of body mass index on first trimester fetal growth [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- HLA sharing among couples appears unrelated to idiopathic recurrent fetal loss in Saudi Arabia [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]